New AHRQ Review Evaluates Treatment Options for Otitis Media with Effusion
In 2010, spending on medical care for high blood pressure totaled nearly $43 billion, almost half of which—$20 billion—went to purchase prescription medicines. (Source: Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey Statistical Brief #404, Expenditures for Hypertension among Adults Age 18 and Older, 2010 Estimates for the U.S. Civilian Noninstitutionalized Population.)
- New AHRQ Review Evaluates Treatment Options for Otitis Media with Effusion.
- One-Quarter of U.S. Adults Need Medical Care for Two or More Chronic Diseases, AHRQ Study Finds.
- New AHRQ Funding Opportunity for Patient Centered Outcomes Research (PCOR) Institutional Mentored Career Development Program.
- Register for May 9 Web Event on Care Coordination in Patient-Centered Medical Homes.
- Register for May 14 Webinar on Advanced Methods in Delivery System Improvement Research.
- May 16 Webinar To Highlight Medication Adherence Report.
- AHRQ in the professional literature.
Patients with otitis media with effusion (OME) benefit from placement of tympanostomy tubes and removal of the adenoids, either alone or in combination, according to a new AHRQ-funded research review. The treatment options for OME, a collection of fluid in the middle ear that presents without symptoms of acute infection, decrease its duration by up to 2 years and improve hearing by up to 1 year. However, results were mixed about any additional potential benefit of using both treatment options, and evidence of potential harms was associated with each. Drainage from the ear is common after placement of tympanostomy tubes and can be persistent; post-surgical hemorrhage, although rare, can result from adenoidectomy. Consistent with current guidelines, newer evidence did not show that nasal or oral steroids provide any benefit. Additional research is needed to support treatment decisions in subpopulations, including adults; children with coexisting conditions such as craniofacial abnormalities or Down syndrome; and children who have received pneumococcal vaccination, which is associated with a reduced risk of acute otitis media. Select to access the research review, Otitis Media With Effusion: Comparative Effectiveness of Treatments.
In 2009, about one-quarter of U.S. adults were treated for two or more of 20 relatively common chronic conditions such as high blood pressure, elevated cholesterol, and diabetes, a new AHRQ-authored study finds. About 18 percent of all adults received medical care for two or three of these chronic conditions, and another 7 percent were treated for four or more of the conditions, according to a study that appeared in the April 25 issue of Preventing Chronic Disease. White adults were the most likely to be treated for two or more of the conditions (28.5 percent), followed by blacks (22 percent), Asians (16 percent), and Hispanics (14 percent). The combination of high blood pressure and elevated cholesterol was the most common pair of diseases treated among persons defined in the study as treated for multiple chronic conditions. For more findings about the study, "Health Care Expenditures for Adults with Multiple Treated Chronic Conditions: Estimates from the Medical Expenditure Panel Survey, 2009," select to access the abstract on PubMed®.
AHRQ is soliciting applications for a new multi-year, large-scale funding opportunity to support the development of scientists studying Patient-Centered Outcomes Research (PCOR). PCOR seeks to integrate evidence into practice and decision-making in the U.S. health care system. AHRQ seeks applications from academic and applied settings, including health care delivery systems, state and local governments, health plans, and research networks that propose a mentored career development program. Such programs will maximize available research, educational and partnership resources, curriculum, and qualified research faculty as mentors. The program design also must monitor and provide well-defined policies and a structure to ensure progress for the candidate. The deadline for applications is July 17. Select to access additional information.
Join the AHRQ Health Care Innovations Exchange on May 9 from 1:00 to 2:00 p.m. EDT for an in-depth dialogue on issues related to care coordination in patient-centered medical homes. The Web event will include information about West Virginia's innovative Medical Home and Transitions Initiatives and the lessons learned in coordinating care for patients in rural locations as well as working with critical populations, such as patients with both mental and physical health disorders and foster children with behavioral issues and asthma. Presenters are David Meyers, M.D., director of AHRQ's Center for Primary Care, Prevention and Clinical Partnerships; James B. Becker, M.D., Medicaid Medical Director, West Virginia Bureau for Medical Services; and William Golden, M.D., Medical Director, Arkansas Medicaid Enterprise at Arkansas Department of Human Services. This Web event is the second in a series designed to share novel experiences in applying principles of accountable care organizations and patient-centered medical homes in practice.
An AHRQ-sponsored webinar on May 14 will explore the concept of statistical process control. The webinar will be held from 1:00 to 2:00 p.m. EDT. Statistical process control uses methods to monitor and control a process to ensure that it operates at its full potential. The presenters are Jill Marsteller, Ph.D., assistant professor at Johns Hopkins Bloomberg School of Public Health, and Stephen Alder, Ph.D., chief of the public health division of the University of Utah's Department of Family and Preventive Medicine. The moderator is AHRQ's Michael Harrison, Ph.D., senior social scientist. Three other webinars will be held June 4, July 15, and a yet-to-be-determined date in December. They will focus on topics related to planning, executing, analyzing and reporting research on delivery system improvement.
An upcoming webinar will highlight findings from a recent AHRQ-funded systematic review of interventions to improve medication adherence. The review included randomized controlled trials of patient, provider, or systems interventions to improve adherence to long-term medications, as well as non-randomized studies of policy interventions to improve medication adherence. The webinar, on May 16 from 1:00 to 2:00 p.m., EDT, will feature report author Christine DeLong Jones, MD, of the University of North Carolina, Chapel Hill, as part of the NIH Adherence Network Distinguished Speaker Series. The report is part of AHRQ's Closing the Quality Gap series. The review found improved medication reconciliation for one or more clinical conditions when patients received lower out-of-pocket expenses, case management, and education with behavioral support. Results from this review will be compared with findings from recent reviews of medication adherence in patients with HIV and AIDS. In addition, areas with limited evidence which could be addressed by future research will be highlighted.
Palmsten K, Hernández-Díaz S, Kuriya B, Solomon DH, Setoguchi S. Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia. Arthritis Care Res 2012 Nov; 64(11):1730-8. Select to access the abstract on PubMed®.
Pollack CE, Platz EA, Bhavsar NA, et al. Primary care providers' perspectives on discontinuing prostate cancer screening. Cancer 2012 Nov 15; 118(22):5518-24. Select to access the abstract on PubMed®.
Altom LK, Deierhoi RJ, Grams J, et al. Association between Surgical Care Improvement Program venous thromboembolism measures and postoperative events. Am J Surg 2012 Nov; 204(5):591-7. Select to access the abstract on PubMed®.
Souza LC, Yoo AJ, Chaudhry ZA, et al. Malignant CTA collateral profile is highly specific for large admission DWI infarct core and poor outcome in acute stroke. AJNR Am J Neuroradiol 2012 Aug; 33(7):1331-6. Select to access the abstract on PubMed®.
Paczynski RP, Alexander GC, Chinchilli VM, et al. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications. Int J Risk Saf Med 2012 Jan 1; 24(3):137-46. Select to access the abstract on PubMed®.
Anderson JB, Czosek RJ, Knilans TK, et al. Postoperative heart block in children with common forms of congenital heart disease: results from the KID database. J Cardiovasc Electrophysiol 2012 Dec; 23(12):1349-54. Select to access the abstract on PubMed®.
Griswold S, Ponnuru S, Nishisaki A, et al. The emerging role of simulation education to achieve patient safety: translating deliberate practice and debriefing to save lives. Pediatr Clin North Am 2012 Dec; 59(6):1329-40. Select to access the abstract on PubMed®.
Lasky T, Greenspan J, Ernst FR, et al. Pediatric vancomycin use in 421 hospitals in the United States, 2008. PLoS One 2012; 7(8):e43258. Select to access the abstracton PubMed®.'
Page originally created May 2013
The information on this page is archived and provided for reference purposes only.